Search
for
Sort by
Research 30 of 1000+
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous drug reactions
- Cutaneous Drug Reaction Case Reports
- Identification of drug-specific public TCR driving severe cutaneous adverse reactions
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cutaneous adverse drug reaction associated with topical use of benzyl benzoate in a dog
- A clinical study of cutaneous adverse drug reactions
- Cutaneous Adverse Drug Reactions (CADRs) to COVID19 vaccines: A case series
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- A Review of Adverse Cutaneous Drug Reactions Resulting from the Use of Interferon and Ribavirin
- Chemotherapy and Cutaneous Drug Reactions
- Faculty Opinions recommendation of Identification of drug-specific public TCR driving severe cutaneous adverse reactions.
- Anticonvulsant-Induced Cutaneous Reactions
- Cutaneous Reactions to Drugs
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Adverse Cutaneous Reactions to Antipsychotics
- Adverse Cutaneous Reactions to Antidepressants
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Adverse Cutaneous Reactions to Mood Stabilizers
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Dermatological manifestations of COVID-19 and its therapies: a review
- Nilotinib-Induced Keratosis Pilaris
- DERMATOLOJİK ACİLLER
- Hypersensitivity Diseases
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs